Contact Us | Home
Toll Free No. for USA/Canada:   1-866-279-8368
| Advance Search
 
Currency:  € $ £
Discounted Reports
MARKET RESEARCH SECTOR IN FOCUS
Energy & Resources
FMCG & Retailing
Pharmaceuticals and Healthcare
Textiles
MARKET REPORT DETAIL

Top Ten Suppliers of Synthetic Biology Technology

Enquire | Email | Print

Single User - $2,550       2 to 5 Users - $2,800       6 to 10 Users - $3,050       11to 20 Users - $3,350       21+ Users - $3,650
Published Date: Mar, 2013
Format: PDF
No of Pages: 54
 
 
Select pricing :
Change Currency: € EURO | $ USD | £ GBP
Buy through us and save. We do not add any Tax / Duty including VAT,GST
  • Abstract
  • Table of Contents

REPORT HIGHLIGHTS

This report provides:

Identification of the top 10 companies in the market for synthetic biology technology, and the rationale behind these selections.
Factors taken into account, including technical innovation, market leadership, and commitment to this market via investment in products.

REPORT SCOPE

INTRODUCTION


Recent advances allowing for the better understanding of the ways in which living DNA creates the materials of life have opened remarkable new possibilities in materials science and chemical engineering. According to physicist Freeman Dyson, “The ability to design and create new forms of life marks a turning point in the history of our species and our planet.”

These advances also mark an economic turning point, creating a market vision of synthetic life forms and life processes tailored to produce specific substances. The desired yield of such substances as biofuels can be measured in millions of tons, whereas pharmaceuticals can be measured in grams or milligrams.

The door that is opening is likely to affect important markets for decades. Intense research and development continues to be both privately and publically funded, but the work has emphatically moved out of the laboratory and into the marketplace. Major corporations are putting new intellectual properties to work in new factories in the U.S. and abroad.

The players on this new field include new companies that come directly out of university research riding large holdings of intellectual property and established multinational giants that have the networks necessary to distribute and market the new materials.

Between these two ends of the spectrum, companies are emerging that can intermediately supply the substances and services that bridge the gaps. The result is intricate patterns of interconnection between layers of the new supply chains. Acquisitions up and down these supply chains are frequent, as capital is freely available due to the obvious potential.

This document examines 10 of the top companies in the field and discusses their positions in these complex patterns of supply and demand, as well as their investments and alliances. The chosen companies have effectively positioned themselves to connect the ends of the chain from the specialized tools and materials end or acquired the ability to make the most effective use of these tools and materials.

BCC Research selected 10 companies that deserve recognition as leaders in the industry. Some are large established multinationals that have embraced the new technology. Others are startup pioneers that grow directly out of the research and development process. They are:

Life Technologies
DNA2.0
Origene
Synthetic Genomics
DuPont
Pfizer
Novozymes
Amrys Biotechnologies
Scarab Genomics
British Petroleum

Any top 10 list has subjective elements, and thus five other companies are profiled in less detail.

STUDY GOALS AND OBJECTIVES

This document is a specialty report related to BCC Research report BIO066B by John Bergin. The goal of this document is to provide a more in-depth look at the top-tier synthetic biology companies, as well as some of the second-tier companies that are sure to play important roles in the years to come. More specifically, the objectives include identifying companies that are considered the leaders in their fields, as well as the technological means these companies are using to exploit their markets and dominate their fields.

Synthetic biology markets reviewed in this report include:

-Markets by end-use segment, such as research and development (R&D), diagnostics/pharmaceuticals, energy, chemicals, and agriculture.
-Markets by product type, including enabling products, biologic components, integrated systems, and enabled products.

Other major factors used to determine top companies in the field include:
-Alliances, mergers, and acquisition strategies.
-Financing.
-Intellectual property (i.e., patent) portfolios.

INTENDED AUDIENCE

The study compiles existing and future synthetic biology products and technologies that will be commercially important in the main end -user segments of life science research, pharmaceuticals, diagnostics, energy, chemicals, and agriculture.

This report will be of particular interest to pharmaceutical, chemical, enzyme, energy, agricultural, biotechnology and nanobiotechnology companies, as well as suppliers of genomics tools, DNA synthesis and DNA-sequencing products. It will also help professionals within governments and regulatory agencies to understand the scope and pace of synthetic biology technologies as they reach the market.

SCOPE

This report focuses on 10 selected synthetic biology companies and the key areas in the field driving the industry growth that allows these companies to succeed. Key market segments include synthetic genes, chassis organisms, biofuels, specialty chemicals and pharmaceuticals. Another key area is industry structure, with a focus on strategic alliances and acquisitions, as well as pertinent patent information.

METHODOLOGY

Based on primary and secondary market analysis, this report analyzes the top 10 companies in DNA sequencing, as well as several additional companies worth recognizing. 

Chapter- 1: INTRODUCTION - Complimentary 3 $0
STUDY GOALS AND OBJECTIVES
INTENDED AUDIENCE
SCOPE
METHODOLOGY
RELATED BCC REPORTS
BCC ONLINE SERVICES
DISCLAIMER

Chapter- 2: SYNTHETIC BIOLOGY OVERVIEW 4 $150
HISTORY
TECHNOLOGY

Chapter- 3: MARKETS 9 $638
MARKET OVERVIEW
SYNTHETIC BIOLOGY MARKETS BY END USER INDUSTRY
MARKET PLAYERS
MARKET SEGMENTS
ACQUISITIONS

Chapter- 4: PATENTS 3 $213
Table 11 : INDUSTRY PATENTS BY COMPANY
Figure 1 : PATENTS BY INDUSTRY, COMPANY AND SUBCLASS

Chapter- 5: SYNTHETIC BIOLOGY COMPANY PROFILES 25 $1771
AMYRIS BIOTECHNOLOGIES INC.
BRITISH PETROLEUM
DNA2.0 INC.
E.I. DU PONT DE NEMOURS AND COMPANY
LIFE TECHNOLOGIES INC.
NOVOZYMES A/S
ORIGENE TECHNOLOGIES
PFIZER
SCARAB GENOMICS LLC
SYNTHETIC GENOMICS INC.

Chapter- 6: SYNTHETIC BIOLOGY COMPANY PROFILES 10 $708
EVOLVA SA
GINKGO BIOWORKS
ROCHE LIFE SCIENCES
SOLAZYME INC.
SYNPROMICS LTD.

List of Tables

Table 1 : FORCES DRIVING THE GROWTH OF SYNTHETIC BIOLOGY
Table 2 : LIFECYCLE STAGES IN SYNTHETIC BIOLOGY
Table 3 : GLOBAL SYNTHETIC BIOLOGY ENABLING PRODUCT MARKET BY TYPE, THROUGH 2016
Table 4 : GLOBAL SYNTHETIC BIOLOGY ENABLING PRODUCT MARKET BY INDUSTRY, THROUGH 2016
Table 5 : SYNTHETIC BIOLOGY PRODUCT BREAKDOWN BY END-USER INDUSTRY, 2010–2016
Table 6 : ESTIMATED SYNTHETIC GENE COMPANY MARKET SHARES, 2010
Table 7 : GLOBAL RESEARCH AND DEVELOPMENT MARKET BY PRODUCT TYPE, THROUGH 2016
Table 8 : GLOBAL BIOLOGIC COMPONENT MARKET BY INDUSTRY, THROUGH 2016
Table 9 : GLOBAL SYNTHETIC BIOLOGY ENABLED BIOFUELS MARKET BY FUEL TYPE, THROUGH 2016
Table 10 : INDUSTRY ACQUISITIONS AND THEIR STRATEGIC OBJECTIVES, 2010-2012
Table 11 : INDUSTRY PATENTS BY COMPANY
Table 12 : AMYRIS BIODIESEL ADVANTAGES
Table 13 : SYNTHETIC GENOMICS STRATEGIC ALLIANCES
Table 14 : EVOLVA STRATEGIC ALLIANCES
Table 15 : EVOLVA PRODUCT PIPELINE
Table 16 : SOLAZYME STRATEGIC ALLIANCES
Table 17 : SYNTHETIC BIOLOGY TOP 10 COMPANIES
Table 18 : UPCOMING SYNTHETIC BIOLOGY COMPANY PROFILES

List of Figures

Figure 1 : PATENTS BY INDUSTRY, COMPANY AND SUBCLASS
Figure 2 : MAKING CELLULOSIC ETHANOL
Figure 3 : LIFE TECHNOLOGIES FINANCIAL SNAPSHOT
Figure 4 : GENES REMOVED FROM CLEAN GENOMIC STRAINS OF E. COLI

Related Reports:  

 

Custom Research
If above report doesn't have the business information suitable for your business, we can provide custom research that would be lucrative for your business or enhance your profession. We leverage most comprehensive, affordable, high-quality custom research which will match exact topic & specifications of your choice. Please visit Custom Research page to make an enquiry.

 

Top Go to top of the page

product id: 378865, price: INR 155305, BCC Research

International Travel Grant for Members of
MANLIBNET (Management Libraries Network)
We accept
Phone: +91.22.27810772, 27810773
E-mail: info@bharatbook.com
Hours: Mon to Sat 8:00 AM to 8:00 PM IST
Call USA/Canada 1-866-279-8368
 
GPlus
About Trust Online